Modification of hyaluronan by heavy chains of inter-α-inhibitor in idiopathic pulmonary arterial hypertension. - Wikidata - awgldk - TriplyDB

Modification of hyaluronan by heavy chains of inter-α-inhibitor in idiopathic pulmonary arterial hypertension.

Modification of hyaluronan by heavy chains of inter-α-inhibitor in idiopathic pulmonary arterial hypertension.

http://www.wikidata.org/entity/Q37622593

about

The Rise and Fall of Hyaluronan in Respiratory Diseases Hyperglycemia-Induced Changes in Hyaluronan Contribute to Impaired Skin Wound Healing in Diabetes: Review and Perspective Metal Ion-dependent Heavy Chain Transfer Activity of TSG-6 Mediates Assembly of the Cumulus-Oocyte Matrix.O-linked β-N-acetylglucosamine transferase directs cell proliferation in idiopathic pulmonary arterial hypertension.Hyaluronan Rafts on Airway Epithelial Cells.Hyaluronidase and Hyaluronan Oligosaccharides Promote Neurological Recovery after Intraventricular Hemorrhage.The role of hyaluronan in the pathobiology and treatment of respiratory disease.Versican accumulates in vascular lesions in pulmonary arterial hypertension.Tumor Necrosis Factor-stimulated Gene-6 (TSG-6) Is Constitutively Expressed in Adult Central Nervous System (CNS) and Associated with Astrocyte-mediated Glial Scar Formation following Spinal Cord Injury.Novel methods in pulmonary hypertension phenotyping in the age of precision medicine (2015 Grover Conference series).Concise Review: Mesenchymal Stem Cells Ameliorate Tissue Injury via Secretion of Tumor Necrosis Factor-α Stimulated Protein/Gene 6.Extrinsic and Intrinsic Mechanisms by Which Mesenchymal Stem Cells Suppress the Immune System.Provisional matrix: A role for versican and hyaluronan.Pathological Hyaluronan Matrices in Cystic Fibrosis Airways and Secretions.Rapid clearance of heavy chain-modified hyaluronan during resolving acute lung injury.

P2860

Q26786052-7F9D6C53-BDC5-4177-98E3-ABD224C219CD Q26786057-FF63DB61-5F78-42DA-9008-A56BA50D4E67 Q30380284-AF9B8FEA-DEBB-414F-9602-19351AFB368F Q35328516-57548F2A-ECEF-42F9-BCB5-76803358098A Q36466209-B7B9639D-05D8-4967-B9A7-C053D0F7A2B0 Q36480271-0D591DA3-D46F-42AA-9510-6A8D18EA5CF0 Q36902371-664B9E7B-AF81-4E2D-BAC7-4FE957D08DAC Q37248333-5C24A98E-130C-4A67-8A42-C60A316B95C2 Q37260670-CB267B3A-D950-4EE7-A070-708CEC8D60E1 Q37555447-BF3AE79E-3239-4CC5-82F7-3746F4369B75 Q38314852-16F64614-427B-43D3-A0A3-C979FFF140BD Q38709705-BE45EEC9-DD8C-45CE-BD4C-AB83A72ED4F5 Q39033619-2A7225F6-C70D-49A5-96E6-A76694E4965F Q41631371-F7BDC976-2659-47DD-B7B3-884E10A627B0 Q55353966-B4EFAEC7-713B-42F9-A06D-7408B230817C

P2860

Modification of hyaluronan by heavy chains of inter-α-inhibitor in idiopathic pulmonary arterial hypertension.

http://www.wikidata.org/entity/Q37622593

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 08 January 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Modification of hyaluronan by ...... lmonary arterial hypertension.

@en

Modification of hyaluronan by ...... lmonary arterial hypertension.

@nl

type

label

Modification of hyaluronan by ...... lmonary arterial hypertension.

@en

Modification of hyaluronan by ...... lmonary arterial hypertension.

@nl

prefLabel

Modification of hyaluronan by ...... lmonary arterial hypertension.

@en

Modification of hyaluronan by ...... lmonary arterial hypertension.

@nl

P1433

Q37622593-17EA2681-CE18-4CD7-9D42-555AB2AEEE9C

P1476

Q37622593-021E1DA7-652D-467D-B2B0-0EE2372B28D7

P2093

Q37622593-156E12FC-3F4A-439B-B94E-54B111DD773B

Q37622593-2750B984-F5E7-4D2F-8811-6EDDAB42C93D

Q37622593-403CACDD-B9A4-46CA-8428-066939A544BE

Q37622593-6F5D778F-24EF-4BAA-BA8B-191D774A14D8

Q37622593-75ED874A-E2C7-48F2-AE7E-ADC1BEB4B46A

Q37622593-7BA50587-7C62-4F37-B18D-B298F28032E3

Q37622593-982CD6A8-C366-4984-A921-9AA6C1A0DF0E

Q37622593-BB0AFC3D-C32A-4801-B096-8D677BEB5971

P2860

Q37622593-2687A969-7B1A-429B-ACF4-EB7D2C30FBE6

Q37622593-29170318-65A2-4BD7-AAE3-C11B1027A240

Q37622593-322A098F-481D-4B7B-A67C-A135450C82B5

Q37622593-3BC6C6A2-C810-4F26-AABD-8523F2026807

Q37622593-5F145B18-6213-48EE-803C-BD705C4FD0F2

Q37622593-605114D4-E0A6-443B-82B0-9C2818B7C774

Q37622593-628FA155-0E3B-4C96-AE4D-BF452F471877

Q37622593-71AE8A72-F43C-4615-B9B7-65B00546A8D0

Q37622593-85433ED8-FFEB-4E72-9830-A13626D43DBC

Q37622593-90458A2E-859D-4202-8666-2A16CC43D2AA

P304

Q37622593-4813553B-4BB9-4CA7-BAD5-51837527A7A0

P31

Q37622593-7D423499-D820-49D7-A188-B94DF4D12A74

P356

Q37622593-5F6550D3-5336-49B9-A889-E9BAF0D3E362

P407

Q37622593-B30243FF-4132-4CDE-8FA9-C0ADBA768477

P433

Q37622593-64ED90A2-E047-48FE-85FB-BE0603516BDC

P478

Q37622593-825FED83-AB59-4B72-93F6-9A3EA2949A7D

P577

Q37622593-8E3E5A70-9A54-4467-A235-F3E4BC4B2242

P5875

Q37622593-D1B1A900-B087-45B6-B35F-CDD6EE3C5C6A

P698

Q37622593-4EDD588F-454B-493F-863F-AAFA7A317FB3

P921

Q37622593-70960EDB-24D4-4A8A-8FF4-195B430A8F68

P932

Q37622593-4A6734CB-94A4-4C02-9654-1530CE5861F4

P356

JBC.M113.512491

P1433

Journal of Biological Chemistry

P1476

Modification of hyaluronan by ...... lmonary arterial hypertension.

@en

P2093

Carol F Farver

http://www.w3.org/2001/XMLSchema#string

Jacqueline Loftis

http://www.w3.org/2001/XMLSchema#string

Liping Tian

http://www.w3.org/2001/XMLSchema#string

Mark E Lauer

http://www.w3.org/2001/XMLSchema#string

Metin Aytekin

http://www.w3.org/2001/XMLSchema#string

Raed A Dweik

http://www.w3.org/2001/XMLSchema#string

Suzy A Comhair

http://www.w3.org/2001/XMLSchema#string

Vincent C Hascall

http://www.w3.org/2001/XMLSchema#string

P2860

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

Pulmonary hypertension: the science behind the disease spectrum

Immune and inflammatory mechanisms in pulmonary arterial hypertension

Isolation and characterization of eight tumor necrosis factor-induced gene sequences from human fibroblasts.

Mononuclear leukocytes bind to specific hyaluronan structures on colon mucosal smooth muscle cells treated with polyinosinic acid:polycytidylic acid: inter-alpha-trypsin inhibitor is crucial to structure and function

Tumor necrosis factor-stimulated gene-6 (TSG-6) amplifies hyaluronan synthesis by airway smooth muscle cells

High levels of hyaluronan in idiopathic pulmonary arterial hypertension.

Modern age pathology of pulmonary arterial hypertension.

Hyaluronan matrices in pathobiological processes.

Novel alpha1-adrenergic receptor signaling pathways: secreted factors and interactions with the extracellular matrix.

P304

6791-6798

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1074/JBC.M113.512491

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

289

http://www.w3.org/2001/XMLSchema#string

P577

2014-01-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259630950

http://www.w3.org/2001/XMLSchema#string

P698

24403074

http://www.w3.org/2001/XMLSchema#string

P921

arterial hypertension

P932

3945340

http://www.w3.org/2001/XMLSchema#string